Stockwinners Market Radar for September 01, 2021 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

20:42 EDT Entergy restores power to 107K customers impacted by Hurricane Ida - The company states: "Entergy continues to make substantial restoration progress following Hurricane Ida's destructive path through Southeast Louisiana and Mississippi. After three days of restoration work following Hurricane Ida's landfall, Entergy has restored more than 107,000 customers and powered its New Orleans Power Station to achieve first lights overnight to the Greater New Orleans area. The estimated 950,000 customers affected is second only to Hurricane Katrina's 1.1 million who were left without power. Restoration efforts are ongoing, and crews are working to fully assess damage and develop plans to restore affected areas."

18:11 EDT MGM Resorts launches mobile sports betting in Wyoming - MGM Resorts' BetMGM announced the launch of its industry-leading digital sports betting platform in Wyoming. Wyoming marks the 14th market to offer BetMGM's mobile and online product.

17:53 EDT Genesis Park Acquisition and Redwire shareholders approve business combination - Genesis Park Acquisition and Redwire announced that at GPAC's extraordinary general meeting, GPAC's shareholders voted to approve the previously announced proposed business combination between GPAC and Redwire, as well as all other proposals related to the Business Combination. Approximately 97% of the votes cast at the meeting, representing approximately 73% of GPAC's outstanding shares as of the record date, voted to approve the Business Combination. The business combination is expected to be consummated on or about September 2. Following the consummation of the Business Combination, the combined company will operate as Redwire Corporation and its shares of common stock and warrants are expected to trade on the NYSE beginning on September 3 under the symbols "RDW" and "RDW WS," respectively.

17:34 EDT Synaptics exec McFarland sells 5,382 common shares - In a regulatory filing, Synaptics SVP and General Counsel John McFarland disclosed the sale of 5,382 common shares of the company on August 31 at a price of $188.43 per share.

17:27 EDT Gartner CFO sells 4.3K shares of common stock - In a regulatory filing, Gartner disclosed that its CFO Craig Safian sold 4.3K shares of common stock on August 30th in a total transaction size of $1.31M.

17:20 EDT Chewy drops 9% to $79.23 after Q3, FY21 revenue guidance misses estimates

17:13 EDT PS Business Parks announces acquisition of Port America for $123M - PS Business Parks announced that it has completed the acquisition of Port America, a 717,735 square foot multi-tenant industrial park located in Dallas, Texas, for a total purchase price of $123.0M. The acquisition was funded in part with $72 million of 1031 exchange proceeds generated from the previously announced dispositions of Park East and Monroe business parks in Northern Virginia, and the remainder of the acquisition price was funded with cash on hand.

17:11 EDT Brady raises annual dividend to 90c from 88c per share - A quarterly dividend to shareholders of the company's Class A common stock of 22.5c per share will be paid on October 29 to shareholders of record at the close of business on October 8. This dividend represents the 36th consecutive annual increase in dividends.

17:06 EDT H&R Block officer Gerke sells over $516K in shares - H&R Block officer Thomas Gerke disclosed in a regulatory filing that he had sold 20,000 shares of company stock at $25.83 per share on August 31, for a total transaction value of $516,520.

17:02 EDT Hall of Fame Resort & Entertainment postpones Highway 77 Music Festival - Hall of Fame Resort & Entertainment has postponed the Highway 77 Music Festival as a result of an increase in COVID-19 cases throughout Ohio. The Highway 77 Music Festival, which was scheduled to take place on September 12, is being postponed out of an abundance of caution, and will be rescheduled to a to-be-determined date in summer 2022 - the slate of performers will also be revealed over the coming months. Hall of Fame Village will be automatically issuing full refunds processed to the original method of payment used at the time of purchase.

16:57 EDT C3.ai falls about 9% to $48.45 after Q1 earnings miss and guidance

16:48 EDT Chardan Healthcare Acquisition stockholders approve Renovacor combination - Chardan Healthcare Acquisition 2 (CHAQ) announced the results for the proposals considered and voted upon by its stockholders at its special meeting held on September 1 regarding the proposed business combination with Renovacor, an early-stage biotechnology company developing adeno-associated virus-based gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants. CHAQ reported that all of the various proposals giving effect to the previously announced business combination between CHAQ and Renovacor were approved by approximately 97.3% of the shares of CHAQ common stock voted at the Special Meeting. The closing of the business combination is expected to take place on September 2. Following the closing of the business combination, the combined company will be renamed "Renovacor, Inc." and its common stock and warrants are expected to commence trading on the NYSE under the ticker symbols "RCOR" and "RCOR.WS", respectively, on September 3, 2021. Renovacor will continue to operate under its existing management team led by its CEO Magdalene Cook. The deadline for electing redemptions of CHAQ common stock has passed and the transaction will provide gross proceeds of approximately $95.1M, including $30.0M from the concurrent closing of a previously announced private placement investment in public equity financing.

16:42 EDT Ingersoll-Rand will not participate in SPX Flow strategic alternatives process - Ingersoll Rand (IR) confirmed it will not participate in the SPX Flow (FLOW) strategic alternatives process announced by SPX Flow on July 26. Ingersoll Rand also announced its comprehensive capital allocation strategy noting M&A remains the focal point with a robust strategic, growth-oriented funnel. The company will share further details on a capital allocation strategy call on September 2 at 8 a.m. Eastern Time.

16:38 EDT Janus International Group acquires Access Control - Janus International Group announced its acquisition of Access Control, or ACT, a provider of self-storage access control and low voltage installation and integration services. ACT's integration will help support the rapid growth of the Noke Smart Entry system. ACT, while continuing to operate under its own brand, will merge into Janus' expansive and experienced field services team.

16:33 EDT Costco reports August SSS, ex-gas/FX, rose 9.4% - Costco Wholesale Corporation reported net sales of $15.75 billion for the retail month of August, the four weeks ended August 29 ,an increase of 16.2% from $13.56B last year. For the 16-week fourth quarter ended August 29, 2021, the Company reported net sales of $61.4 billion, an increase of 17.4 percent compared to net sales of $52.3 billion during the similar period last year. For the 52-week fiscal year ended August 29, 2021, the Company reported net sales of $192.1 billion, an increase of 17.7 percent from the $163.2 billion during the similar period last year.

16:33 EDT Moderna submits initial data to FDA for COVID-19 vaccine booster - Moderna announced it has initiated its submission to the U.S. Food and Drug Administration for the evaluation of a booster dose of the Moderna COVID-19 vaccine at the 50 microgram dose level. The company expects to submit data to the European Medicines Agency and other regulatory authorities around the world in the coming days. "We are pleased to initiate the submission process for our booster candidate at the 50 microgram dose with the FDA. Our submission is supported by data generated with the 50 microgram dose of our COVID-19 vaccine, which shows robust antibody responses against the Delta variant," said Stephane Bancel, Chief Executive Officer of Moderna. "We remain committed to staying ahead of the virus and following the evolving epidemiology of SARS-CoV-2. We will continue to generate data and transparently share to support governments and regulators as they make evidence-based decisions regarding future vaccination strategies." The Phase 2 study of mRNA-1273 was amended to offer a booster dose of mRNA-1273 at the 50 microgram dose level to interested participants 6 months following their second dose (n=344). Neutralizing antibody titers had waned significantly prior to boosting at approximately 6 months. A booster dose of mRNA-1273 at the 50 microgram dose level boosted neutralizing titers significantly above the Phase 3 benchmark. After a third dose, a similar level of neutralizing titers was achieved across age groups, notably in older adults. The safety profile following dose 3 was similar to that observed previously for dose 2 of mRNA-1273. These data will be submitted to a peer-reviewed publication.

16:22 EDT Veeva drops 9% to $303.01 after Q2 results, FY22 guidance

16:20 EDT Forian appoints Michael Vesey as CFO - Forian (FORA) has appointed Michael Vesey as Chief Financial Officer effective September 2. Vesey will succeed Clifford Farren, who will remain with Forian in an advisory capacity through the end of the year to ensure an orderly transition. Vesey was most recently CFO of Wayside Technology Group (WSTG), a provider of cyber security, software and technology solutions. Prior to Wayside, Vesey spent nine years at Majesco Entertainment .

16:18 EDT DraftKings launches online sportsbook in Wyoming - DraftKings announced the launch of DraftKings Online Sportsbook in Wyoming, marking the thirteenth state in which its mobile sportsbook is available. Beginning immediately, customers in Wyoming at least 18 years old can now wager on various markets across professional and collegiate sports using DraftKings' mobile sportsbook app. "Legalized sports betting has seen wide-spread growth in just three years and the DraftKings Sportsbook has been at the center of the action," said Matt Kalish, co-founder and president, DraftKings North America. "We are thrilled that Wyoming sports bettors have the opportunity to experience the highly accessible and immersive fan experience along with best in class consumer protections that our product offers millions of skin-in-the-game sports fans."

16:16 EDT NuVasive appoints new CCO and CTO - NuVasive announced new executive leadership roles. Massimo Calafiore has been appointed Chief Commercial Officer and Ryan Donahoe has been appointed Chief Technology Officer. Since joining the company in 2017, Calafiore has held various leadership roles with increasing levels of responsibility, most recently serving as EVP, Global Business Units. Prior to NuVasive, he spent 16 years supporting and leading the U.S. business for Waldemar Link. During his 15 years at NuVasive, Donahoe has played an integral role in more than 20 issued and pending patents. In connection with this new leadership structure, Brent Boucher, EVP, Global Commercial, will transition from the company.

16:14 EDT Armstrong World CFO Brian MacNeal to retire - Armstrong World announced the planned retirement of Brian MacNeal, chief financial officer, effective May 1, 2022. MacNeal joined Armstrong in 2014 as vice president. The company has initiated a search with the assistance of an executive search firm that will include both internal and external candidates to identify a successor for this position. MacNeal will continue to serve as CFO through the search process and assist during the subsequent transition.

16:13 EDT First Horizon provides update on impact of Hurricane Ida - First Horizon will postpone the IBERIABANK operating system conversion and rebranding until 1Q22 in the wake of Hurricane Ida. Additionally, the company now expects pre-tax merger integration costs of $520M-$530M, an increase of $20M-$30M, and that it will achieve its targeted $200M of pre-tax annualized merger cost saves by 4Q22. The company also announced an additional $1M pledge to assist with disaster recovery efforts for communities affected by the storm. Clients have experienced no disruption to banking services outside of banking center closures. While assessment of damages to clients, associates and communities is ongoing, First Horizon currently estimates the following impacts: an estimated 8,350 clients with approximately $3.0B, or 5% of loans outstanding are in areas impacted by the hurricane; client assistance includes: waived foreign ATM fees and surcharge credits, free replacement checks, loan options to assist with recovery, fee reversals and other special considerations. The company operates 27 banking centers and seven offices in the affected markets - New Orleans, Baton Rouge and Houma, Louisiana. Assessments to date include no catastrophic damage to physical locations, limited water intrusion, operational centers have no major damage and mortgage offices are fully functional. Nine banking centers are fully functional and expects to recover four additional banking centers over the next few days.

16:13 EDT INmune Bio says XPro found to decrease multiple species of pTau in AD patients - INmune Bio announced that XPro, the company's selective DN-TNF inhibitor candidate for the treatment of Alzheimer's disease, or AD, treatment resistant depression, and other neurological diseases where neuroinflammation is implicated, has been found to decrease multiple species of Phospho Tau, or pTau, and improve neuroimaging biomarkers of myelination in patients with AD. These biomarker data are from the analysis of the company's recently concluded Phase 1 study of XPro in Alzheimer's patients. AD patients treated with 1.0 mg/kg of XPro once a week for three months had a 46% reduction is CSF pT217 and a lesser reduction in pT181. While pT181 is recognized as the standard CSF biomarker of AD, recent studies suggest that pT217 has higher discriminative accuracy for AD and a stronger correlation with amyloidosis and cognitive decline. The company also reported improvement in white matter MRI metrics, including a 16% improvement in radial diffusivity, a biomarker of remyelination. These data add to previously reported improvements in apparent fiber density and free water. In each metric, improvements continued throughout the 12-month extension trial. The company plans to start enrolling a blinded, randomized Phase 2 trial in patients with mild AD by the end of 2021. The six-month trial will enroll 200 patients at centers across North America and Australia. Patients will receive 1mg/kg of XPro weekly by subcutaneous injection. The primary endpoint is EMACC, a sensitive measure of cognitive function.

16:12 EDT Acadia Pharmaceuticals CFO Ridloff to leave company - Acadia Pharmaceuticals announced that Elena Ridloff, Executive Vice President and Chief Financial Officer, will be leaving the company effective September 10, 2021 to join another biopharmaceutical company. Mark Schneyer, Senior Vice President, Business Development and Chief Business Officer, will serve as Acadia's interim Chief Financial Officer. The company is conducting a formal search for a new CFO. "On behalf of all of us at Acadia, I want to thank Elena for her leadership and contributions which played an important role in supporting Acadia's growth and long-term business strategy, and we wish her well in her future endeavors," said Steve Davis, Chief Executive Officer.

16:08 EDT Oncternal names Steven Hamburger SVP regulatory affairs, quality assurance - Oncternal Therapeutics announced the appointment of Steven Hamburger, Ph.D. as Senior Vice President of Regulatory Affairs and Quality Assurance.Dr. Hamburger brings over 35 years of global drug development experience leading to numerous marketing authorizations in oncology, rare diseases and other therapeutic areas, across multiple geographies. Most recently, Steve was responsible for clinical regulatory affairs at FerGene and was Vice President and Head, Regulatory Affairs at Checkmate Pharmaceuticals, and Regulatory Affairs and Quality Assurance at Tarveda Therapeutics. Steve also led global regulatory efforts for both biotech and large pharmaceutical companies including Castle Creek Pharmaceuticals, Baxalta, Immunomedics and Savient Pharmaceuticals, and held senior regulatory affairs positions at Takeda/Millennium, Johnson & Johnson/Janssen/Ortho Biotech, Eli Lilly, and Zeneca/ICI Pharmaceuticals.

16:08 EDT Nutanix reports Q4 ARR up 83% at $878.7M - Reports Q4 annual contract value up 26% at $176.3M and average contract term of 3.4 years vs. 3.8 years prior.

16:06 EDT Asana names Anne Raimondi as new COO - Asana announced that Anne Raimondi has been appointed Asana's newCOO. Raimondi succeeds Chris Farinacci, who had served as Asana's COO since 2015. Farinacci will retire at the end of the current fiscal year.

16:05 EDT Assembly Biosciences decides to discontinue clinical development ofABI-H2158 - Assembly Biosciences announced its decision to discontinue development of ABI-H2158 following the observation of elevated ALT levels consistent with drug-induced hepatotoxicity in an ongoing Phase 2 trial. "Patient safety is always our priority, which is why we have elected to discontinue the development of 2158," said John McHutchison, AO, MD, chief executive officer and president of Assembly Bio. "We remain committed to our pursuit of developing finite and curative therapies for individuals with chronic hepatitis B, and our strategy remains unchanged. We will continue to evaluate our core inhibitor portfolio, to ultimately choose the best and safest candidate to take forward into later stage clinical trials as we believe this mechanism will be an important and key component of future curative regimens. We remain focused on expeditiously advancing our additional clinical programs, including the two ongoing Phase 2 triple combination studies, accelerating the clinical development for 3733 and 4334, and progressing additional research programs in our HBV portfolio with complementary mechanisms. And, as always, we will continue evaluating strategic opportunities to build additional value in the company's pipeline." The Phase 2 clinical study for 2158 is a multi-center, randomized, placebo-controlled trial in treatment-naive patients with HBeAg positive or HBeAg negative chronic hepatitis B infection without cirrhosis. A total of 88 patients were enrolled and randomized three-to-one to receive either 300 mg 2158 plus entecavir or placebo plus entecavir once daily for up to 72 weeks. In the study, two patients receiving 2158 experienced Grade 4 elevations in ALT leading to drug discontinuation. Two additional patients also receiving 2158 developed Grade 3 ALT elevations. No alternate causes for the ALT elevations have been identified, and these four patients continue to be closely monitored. The company has communicated the findings with the U.S. Food & Drug Administration and has voluntarily chosen to discontinue development of 2158 and the Phase 2 study.

16:02 EDT DraftKings, BetMGM obtain online sports betting licenses in Wyoming - Ryan Butler of Action Network tweeted: "DraftKings (DKNG) has earned Wyoming's first online sports betting license. It is set to launch as early as this afternoon. Wyoming will be the first state to both pass a 2021 sports betting bill and take a bet this year." In a separate tweet he said, "BetMGM (MGM) has also earned a Wyoming's online sports betting license. It too is set to take bets as early as this afternoon. No other books are pending in the state, but several additional operators have expressed interest in the market. Reference Link

16:01 EDT PEMCO delivers second Boeing 737-700 FlexCombi - Air Transport Services Group, Inc. (ATSG) subsidiary PEMCO Conversions has delivered a second Passenger-to-FlexCombi converted aircraft to Bahrain-based Chisholm Enterprises, an internationally recognized provider of tailored aviation and business solutions in the Middle East. Chisholm subsidiary Texel Air, a non-scheduled cargo airline, will operate the Boeing (BA) 737-700FC from Bahrain International Airport. "We have shared a very successful history with PEMCO Conversions," said John Chisholm, chairman and owner of Chisholm Enterprises, "having received and deployed the first B737-700 FlexCombi in August 2020, as well as four previous B737-300 converted freighters."

15:40 EDT Chatham Asset Management calls for continued deleveraging at R.R. Donnelley - Chatham Asset Management, a private investment firm which manages funds that beneficially own approximately 14.9% of the outstanding common stock and which is the largest bondholder of R.R. Donnelley & Sons, made public a letter sent to RRD's Board of Directors regarding its decision to amend and extend the company's "value-destructive" stockholder rights plan. The letter stated in part: "Today, we write in response to RRD's Board of Directors' highly problematic decision to renew its poison pill, without shareholder input until next year's annual meeting, which has traditionally been held in May. We believe this action, despite considerable shareholder opposition to the poison pill at the 2021 annual meeting of shareholders, raises significant corporate governance issues and demonstrates the urgent need to add new directors to the Board who have been recommended by shareholders and have strong capital allocation and corporate governance expertise. That fact that the Board continues to defend and extend the poison pill despite clear opposition from its stockholders, and over and above the objections of shareholder advisory firms, such as Institutional Shareholder Services, who have clearly opposed retention of the poison pill, only serves to demonstrate that the Board's interests are not aligned with those of its stockholders and fresh perspectives are sorely needed in the boardroom... As RRD's largest equity and debt holder, our interests are aligned and our primary goal is the maximization of stockholder value. Accordingly, we believe that the Board needs new directors with strong corporate governance and capital allocation expertise to improve the Company's operating cost structure and explore better ways to allocate the Company's capital, including possibly selling non-core assets and using the proceeds to reduce debt or undertake share repurchases. We believe a refreshed Board with the right expertise and alignment can lead to margin and free cash flow improvement, higher EBITDA and an improved share price."

14:36 EDT Credit Acceptance confirms resolution of litigation with Massachusetts AG - Credit Acceptance Corporation announced the finalization of a settlement resolving litigation with the Massachusetts Attorney General, the material terms of which were previously disclosed in April 2021. "This matter was vigorously contested. However, Credit Acceptance believes it to be in the best interest of the company to conclude this litigation, and is pleased to announce its resolution. The company looks forward to continuing to serve customers in the Commonwealth of Massachusetts through its financing programs... Under the agreement, Credit Acceptance made no admission of liability," the company stated.

13:56 EDT Twitter announces launch of 'Super Follows' for paid subscriber-only content - Esther Crawford, Staff Product Manager for Twitter, stated in a blog post: "Twitter is where people go to have real conversations with others who share their interests. These incredible conversations make Twitter what it is and we want to support the people creating them so that Twitter continues to be a place to connect with others authentically. This year, we've started to do more to support the voices driving these conversations with money, through Tip Jar and Ticketed Spaces. Today we're excited to introduce Super Follows, a new way for people to earn monthly revenue by sharing subscriber-only content with their followers on Twitter. With Super Follows, people can create an extra level of conversation on Twitter (sharing bonus Tweets and more!) to interact authentically with their most engaged followers - all while earning money... Through Super Follows, people can set a monthly subscription of $2.99, $4.99 or $9.99 a month to monetize bonus, "behind-the-scenes" content for their most engaged followers on Twitter. And followers get extra special access to their unfiltered thoughts, early previews and subscriber-only conversations from their favorite accounts... Right now, people in the U.S. and Canada using iOS can Super Follow select accounts and we'll be rolling it out to people using iOS globally in the next few weeks. Creators can share Super Follows Tweets on iOS only and Super Follows Tweets can be viewed on iOS, with Android and twitter.com coming soon." Reference Link

13:35 EDT Credit Acceptance settles with Massachusetts over auto loans for $27.2M - Massachusetts Attorney General Maura Healey announced Credit Acceptance Corporation (CAC) will pay $27.2M to settle a lawsuit "over a variety of alleged unfair practices relating to the company's role in the origination, collection, and securitization of subprime auto loans." Over 3,000 borrowers across the state are expected to be eligible for settlement funds. The AG's Office sued Credit Acceptance in August 2020 over the company's practices relating to the origination, collection, and securitization of subprime auto loans. Shares of Credit Acceptance are up 4% to $601.83 following the news.

13:18 EDT Tesla CEO says Roadster 'should ship' in 2023 - In reply to a question posed on Twitter, Tesla CEO Elon Musk tweeted: "2021 has been the year of super crazy supply chain shortages, so it wouldn't matter if we had 17 new products, as none would ship. Assuming 2022 is not mega drama, new Roadster should ship in 2023." Reference Link

12:34 EDT Credit Acceptance up 8% to $588.11 after Massachusetts announces settlement

12:22 EDT AbbVie drops 7% after FDA adds warning to arthritis drug Rinvoq

12:16 EDT Nikola adds Quinn Company to dealer network - Nikola Corporation announced the continued expansion of its Class 8 truck sales and service coverage with the addition of Quinn Company, a leading provider of on-highway truck service and construction equipment in the Central and Southern California regions. The addition of Quinn Company to the Nikola dealer network will include sales and service facilities across 15 counties.

12:00 EDT Regis falls -7.2% - Regis is down -7.2%, or -39c to $5.03.

12:00 EDT AbbVie falls -11.5% - AbbVie is down -11.5%, or -$13.84 to $106.94.

12:00 EDT Rockley Photonics rises 17.7% - Rockley Photonics is up 17.7%, or $1.24 to $8.25.

11:59 EDT Twitter launches 'Safety Mode' that block accounts for 7 days - Twitter introduced "Safety Mode, a new feature that aims to reduce disruptive interactions." Starting today, the company is rolling out this safety feature to a small feedback group on iOS, Android, and Twitter.com, beginning with accounts that have English-language settings enabled. "Safety Mode is a feature that temporarily blocks accounts for seven days for using potentially harmful language - such as insults or hateful remarks - or sending repetitive and uninvited replies or mentions. When the feature is turned on in your Settings, our systems will assess the likelihood of a negative engagement by considering both the Tweet's content and the relationship between the Tweet author and replier. Our technology takes existing relationships into account, so accounts you follow or frequently interact with will not be autoblocked," the company said in a blog post. Reference Link

11:53 EDT CD Projekt targets 'late 2021' for next-gen updates for 'Cyberpunk,' 'Witcher 3' - CD Projekt (OTGLY) said it is targeting "late 2021" dates for the next-generation console updates for "The Witcher 3: Wild Hunt" and "Cyberpunk 2077." Both games are currently available on PC, Xbox One (MSFT), and PlayStation 4 (SONY), with the free upgrades expected to optimize the games' performance and visuals for Xbox Series X/S and PlayStation 5. Reference Link

11:42 EDT Harvest Health & Recreation announces planned divestiture of Florida license - Harvest Health & Recreation (HRVSF) announced the signing of a definitive agreement to divest its Medical Marijuana Treatment Center license issued by the Florida Department of Health. Planet 13 Holdings (PLNHF) has agreed to purchase the license for $55 million in cash. The planned divestiture includes the sale of the license only and does not include any planned or operational facilities. Closing of the divestiture of the Florida license remains subject to the customary satisfaction of closing conditions including regulatory approvals and the closing of the planned acquisition of Harvest by Trulieve Cannabis Corp. (TCNNF).

11:19 EDT Apollo Funds complete acquisition of Yahoo - Apollo Global (APO) announced that funds managed by its affiliates - the "Apollo Funds" - have completed the acquisition of Yahoo - formerly Verizon Media. With the close of the transaction, Yahoo will now operate as a standalone company under Apollo Funds. Verizon (VZ) has retained a 10% stake in Yahoo.

11:13 EDT Regal Beloit holders approve share issuance for Rexnord unit deal - Regal Beloit (RBC) announced that shareholders today approved the issuance of shares necessary to complete the previously announced combination of Rexnord's (RXN) Process & Motion Control business with Regal in a Reverse Morris Trust transaction. In addition, Regal shareholders approved the amendment and restatement of Regal's Articles of Incorporation to effect a change in the company name to "Regal Rexnord Corporation" and to increase the number of authorized shares of Regal common stock. Regal expects the closing of the transaction joining the company with Rexnord's PMC business to occur early in Q4.

11:01 EDT Dish's Boost Mobile acquires Gen Mobile, terms undisclosed - Dish Network's Boost Mobile announced its plan to acquire Gen Mobile, a prepaid mobile service. The acquisition "enables Boost Mobile to distribute to a larger segment of the low-income population while continuing its mass market expansion," the company said in a statement. Boost will procure the Gen Mobile brand, customer base, existing distribution network, technology and its wireless team, it added. After the acquisition closes, Robert Yap will continue to lead the Gen Mobile business. Gen Mobile will remain headquartered in Los Angeles. The transaction is subject to customary closing conditions. Terms of the deal were not disclosed.

10:31 EDT Rexnord stockholders approve PMC business combination with Regal Beloit - Rexnord Corporation (RXN) announced that its stockholders voted to approve the previously announced combination of Rexnord's Process & Motion Control Business with Regal Beloit Corporation (RBC) in a Reverse Morris Trust transaction at the special meeting of stockholders held earlier today. As previously announced, the consummation of the Transaction is expected to occur early in the fourth quarter of 2021, subject to the satisfaction of the remaining closing conditions.

10:22 EDT FDA requires warnings to arthritis medicines after Xeljanz safety study - Based on a completed Food and Drug Administration review of a randomized safety clinical trial, the agency concluded there is an increased risk of serious heart-related events such as heart attack or stroke, cancer, blood clots, and death with the arthritis and ulcerative colitis medicine Xeljanz, made by Pfizer (PFE). The FDA is requiring new and updated warnings for two other arthritis medicines in the same drug class as Xeljanz, called Janus kinase inhibitors, Eli Lilly's (LLY) Olumiant and AbbVie's (ABBV) Rinvoq. Olumiant and Rinvoq have not been studied in trials similar to the large safety clinical trial with Xeljanz, so the risks have not been adequately evaluated, the FDA said. However, since they share mechanisms of action withXeljanz, FDA considers that these medicines may have similar risks as seen in the Xeljanz safety trial. Reference Link

10:05 EDT Wrap announces deployment of two BolaWrap devices by Houston Police - Wrap Technologies released new bodycam footage of a double BolaWrap deployment in Houston, Texas. The video showed how the BolaWrap assisted officers in safely and humanely restraining a noncompliant subject in crisis. With approximately 5,300 officers and 1,200 civilian support personnel, Houston Police Department is the United States' fifth-largest municipal police department, serving its fourth-largest city. On June 16, 2021, Houston Police Department responded to a call about a subject who was trespassing, had a pocketknife, and seemed to be in crisis. The subject was uncooperative, so officers deployed two BolaWrap devices simultaneously. One wrapped around the subject's upper legs, and the other wrapped around his ankles, effectively subduing the subject. As a result, officers were able to safely approach and place the subject into handcuffs without force or injury.

10:02 EDT Natures Sunshine Products launches new skincare line l'amara - Nature's Sunshine Products announced the launch of its new clean beauty line, l'amara today. The collection features a blend of natural ingredients from land and sea to boost natural beauty. Nature's Sunshine first introduced the l'amara line in Asia in 2020. The company said, "The l'amara collection features a proprietary blend of antioxidant-rich fermented green tea leaves and soothing algae, delivering naturally derived pre/probiotics with a blend of antioxidants and skin-nourishing nutrients to revitalize skin. Each product has been tested by dermatologists and undergone Nature's Sunshine's own rigorous testing to ensure each formula delivers clean, natural beauty."

10:00 EDT Bright Scholar falls -6.2% - Bright Scholar is down -6.2%, or -21c to $3.15.

10:00 EDT Dycom falls -6.8% - Dycom is down -6.8%, or -$5.15 to $70.18.

10:00 EDT PVH Corp. rises 13.3% - PVH Corp. is up 13.3%, or $13.90 to $118.69.

09:59 EDT SOC Telemed CEO John Kalix resigns, Christopher Gallagher appointed - SOC Telemed announced the appointment of Christopher Gallagher as its Chief Executive Officer. Gallagher has served as a member of the company's board and as President of Access Physicians, a division of SOC Telemed, since March. Gallagher previously served as the Chief Executive Officer of Access Physicians Management Services Organization, an acute care telemedicine provider, from its founding in 2013 through the date we acquired that company in March. SOC also announced the appointment of David Mikula as its Chief Operating Officer. Mikula has served as Chief Operating Officer of Access Physicians, a division of SOC Telemed, since March. Mikula previously served as the Chief Operating Officer of Access Physicians from December 2017 through the date it acquired that company in March. On September 1, John Kalix resigned from his roles as Chief Executive Officer of the company and from the board. Additionally, Hai Tran resigned from his roles as President and Chief Operating Officer.

09:50 EDT Focus Universal Inc trading halted, volatility trading pause

09:49 EDT Facebook launches Facebook Fantasy Games - In a blog post, Daniel Fletcher, product manager, entertainment for Facebook, said, "Today, we're rolling out Facebook Fantasy Games in the US and Canada on the Facebook app for iOS and Android. Facebook Fantasy Games are free, simple prediction games that help fans enjoy sports, TV shows and pop culture content together. These games bring the social fun of traditional fantasy sports to simpler formats that are easy to play for people new to prediction games, while still engaging enough for more seasoned players. In addition to public leaderboards, players can create their own fantasy league and compete against friends and other fans. Leagues, which can be public or private, will allow members to compare scores to others in the league and provide a place for members to share picks, reactions and comments...Available today, daily sports prediction game Pick & Play Sports is the first game we're launching, in partnership with Whistle Sports. Fans will get points for correctly predicting the winner of a big game, the points scored by a top player or specific events that unfold during a match. Players can earn bonus points for building a streak of correct predictions over a series of days. In the upcoming months, we will introduce new games with TV shows like CBS's Survivor and ABC's The Bachelorette, sports leagues like Major League Baseball and LaLiga Santander and premier digital publishers like BuzzFeed." Reference Link

09:47 EDT VanEck Vectors Rare Earth/Strategic Metals ETF falls -4.8% - VanEck Vectors Rare Earth/Strategic Metals ETF is down -4.8%, or -$5.65 to $112.69.

09:47 EDT PVH Corp. rises 14.0% - PVH Corp. is up 14.0%, or $14.72 to $119.51.

09:47 EDT Anaplan rises 16.7% - Anaplan is up 16.7%, or $10.03 to $70.00.

09:44 EDT Vinco Ventures trading halted, volatility trading pause

09:37 EDT TerrAscend to acquire Gage Cannabis for $545M - TerrAscend Corp. (TRSSF) and Gage Growth Corp. (GAEGF) announced that they have entered into a definitive arrangement agreement pursuant to which TerrAscend will acquire all of the issued and outstanding subordinate voting shares of Gage by way of a court-approved plan of arrangement under the Canada Business Corporations Act. Under the terms of the Arrangement Agreement, shareholders of Gage will receive 0.3001 of a common share of TerrAscend for each Gage Share held, representing a total consideration of approximately $545M based on the closing price of TerrAscend on August 31, 2021. The Exchange Ratio implies a consideration of $2.11 per Gage Share, representing a 18% premium based on the closing prices of both companies' shares on the Canadian Securities Exchange on August 31, 2021. Upon completion of the Transaction, the combined business will have operations in 5 states and Canada, including 7 cultivation and processing facilities and 23 operating dispensaries serving both medical and adult-use cannabis markets in the U.S. and Canada. The Transaction will be effected by way of a court-approved plan of arrangement pursuant to the Canada Business Corporations Act. Under the terms of the Arrangement Agreement, TerrAscend will acquire all of the issued and outstanding Gage Shares, with each Gage Shareholder receiving 0.3001 of a common share in the capital of TerrAscend for each Gage Share, implying a price per Gage Share of $2.11 which represents an 18% premium based on the closing prices of both companies shares on August 31, 2021. After giving effect to the Transaction, Gage Shareholders will hold approximately 19.8% of the issued and outstanding pro forma TerrAscend Shares. In connection with the Transaction, all outstanding options and warrants of Gage will be exchanged for replacement options and warrants of TerrAscend, exercisable to acquire that number of common shares of TerrAscend as is equal to the Exchange Ratio multiplied by the number of Gage Shares that the holders of the options or the warrants would have acquired if such holders had exercised such options or warrants immediately prior to the effective time of the Transaction. In connection with and as an integral part of the Transaction, TerrAscend, through a wholly-owned and controlled subsidiary has entered into a membership interest purchase agreement with the owners of the licenses that Gage supports in the State of Michigan to acquire, subject to regulatory approvals, all of the issued and outstanding membership interests of each of the Licensed Operators and/or all of the licenses owned by such Licensed Operators. As part of the Transaction, exchangeable shares indirectly owned by Rami Reda, an insider of Gage, will be transferred to TerrAscend in exchange for TerrAscend Shares on the basis of the Exchange Ratio. Certain exchangeable units held by Mike Hermiz, a director and officer of Gage, will remain in place following the closing of the Transaction. In this regard, Mr. Hermiz, Gage, TerrAscend and certain subsidiaries of Gage will, concurrently with the closing of the Transaction, enter into a support agreement that will, among other things, govern the terms and conditions under which Mr., Hermiz will be entitled to exchange his exchangeable units into TerrAscend Shares on the basis of the Exchange Ratio. In addition, all super voting shares of Gage held by Mr. Hermiz will be transferred to TerrAscend in connection with the closing Transaction for no consideration. Additional details of the Transaction will be described in the management information circulars that will be mailed to Gage Shareholders and TerrAscend shareholders, respectively, in connection with a special meeting of Gage Shareholders and a special meeting of TerrAscend Shareholders expected to be held in the fourth quarter to approve the Transaction. Additional information regarding the terms of the Arrangement Agreement, the background to the Transaction, the rationale for the recommendations made by the Special Committees and how shareholders can participate in and vote at the Gage Meeting or TerrAscend Meeting will be provided in the Gage Circular or TerrAscend Circular, as applicable. Subject to the receipt of all required approvals, closing of the Transaction is expected to occur in the first half of 2022. The Arrangement Agreement also provides for the payment of a termination fee of $30M by TerrAscend or Gage, as applicable, if the Transaction is not completed under certain limited circumstances.

09:30 EDT Adagene Inc (ADS) trading halted, volatility trading pause

09:25 EDT Amazon opens two new central Maryland delivery stations - "Amazon is excited to announce the opening of two delivery stations in Hanover and Baltimore. The 72,000 square foot facility at 2100 Van Deman Street is the first delivery station in Baltimore city. The 194,000 square foot facility at 7226 Preston Gateway Drive is the company's third delivery station in Hanover. In celebration of the station launches, Amazon donated 650 pre-filled backpacks to Dundalk Elementary School and pajamas for critically ill children to Casey Cares Foundation. Delivery stations power the last mile of Amazon's order process and help speed up deliveries for customers. Packages are shipped to a delivery station from neighboring Amazon Fulfillment and Sortation Centers, loaded into delivery vehicles and delivered to customers. Delivery stations offer entrepreneurs the opportunity to build their own business delivering Amazon packages, as well as independent contractors the flexibility to be their own boss and create their own schedule delivering for Amazon Flex. Combined, the two stations will collaborate with ten Delivery Service Partners," said the company in a statement.

09:22 EDT DTE Energy announces $70M investment to combat weather-related power outages - DTE Energy announced an incremental $70 million investment to combat extreme weather-related power outages. The plan will direct additional funds to remove trees and trim branches away from power lines. Trees are responsible for almost all of the time DTE customers are without power during extreme high wind events. In areas where tree trimming has been completed, communities have experienced, on average, 60% fewer outages.The $70 million is on top of the $190 million DTE currently spends on tree trimming every year. The investment will not impact customers' bills. The DTE service area experienced five tornadoes this summer and eight storms with tropical force wind gusts of 39 to 74 miles per hour. High winds and extreme moisture in the ground uprooted trees which pulled down wires and poles. For example, DTE crews replaced 450 broken poles resulting from the Aug. 11 catastrophic storm that caused more than 500,000 customers to lose power. The plan, which adds $70 million to DTE's annual $190 million tree trimming program, was filed yesterday with the Michigan Public Service Commission.

09:18 EDT Matterport appoints Seth Finkel as VP, public sector - Matterport, announced the appointment of Seth Finkel as VP Public Sector. Finkel will lead strategy and revenue growth for government agency markets as Matterport enters the public sector and digitizes U.S. Government facilities, infrastructure and strategic initiatives. Seth will help position the untapped value of Matterport's spatial data and industry-leading 3D capture technology for government agencies looking to advance their facility and infrastructure-based programs. He was previously VP Advanced Technology at Aventum, a 34,000 person organization which provides technical and engineering services to all 50 U.S. states, as well as 105 global countries and territories.

09:15 EDT Support.com says ISS, Glass Lewis support proposed transaction with Greenidge - Support.com announced that both of the leading independent proxy advisory firms, Institutional Shareholder Services and Glass Lewis & Co. have recommended that Support.com shareholders vote for the proposed transaction with Greenidge Generation Holdings at Support.com's upcoming special meeting scheduled for September 10 . Both ISS and Glass Lewis have recommended that shareholders vote for all proposals to be presented at the special meeting, in accordance with the unanimous recommendation of the Support.com Board. "We welcome the favorable recommendations from ISS and Glass Lewis and are pleased that both proxy advisory firms recognize the compelling merits of the transaction with Greenidge," said Lance Rosenzweig, Support.com President and Chief Executive Officer. "The ISS and Glass Lewis recommendations reaffirm the Board's determination that the transaction with Greenidge provides the best path for maximizing value for Support.com shareholders."

09:12 EDT Scientific Games signs 10-year contract with Azerbaijan National Lottery - Scientific Games has signed a comprehensive, 10-year agreement with Azerlotereya to support the national lottery and sports betting concession in Azerbaijan in southwestern Asia. The deal expands the company's partnership with Demiroren to Azerbaijan, where Demiroren is now operating the national lottery Azerlotereya. Scientific Games will exclusively supply retail and digital instant games, and its AEGIS omni-channel bet management system delivering iLottery, retail instant games and draw games nationally.

09:10 EDT Ardagh Group launches share-for-share exchange offer with Ardagh Metal Beverage - Ardagh Group (ARD) intends to launch an exchange offer early next week to acquire all of its outstanding Class A Common Shares in exchange for a portion of the shares of Ardagh Metal Packaging (AMBP) currently outstanding and held by AGSA. The AMPSA Shares commenced trading on NYSE on August 5 following the completion on August 4 of the transactions among AGSA, AMPSA and Gores Holdings V, with AGSA retaining an 82% ownership interest in AMPSA. Following the expiration of the exchange offer, each AGSA Share validly tendered and not withdrawn will be exchanged for 2.5 AMPSA Shares. Following the proposed exchange offer, AGSA intends to initiate the process for delisting of the AGSA Shares from the NYSE and their deregistration, which is intended to eliminate the inefficiencies resulting from both AGSA and AMPSA being publicly traded companies and having separate public reporting obligations. Completion of the proposed exchange offer will be subject to the satisfaction of customary conditions, as well as a condition that at least two thirds of the AGSA Shares will be validly tendered into the exchange offer and not withdrawn.

09:07 EDT Katapult announces plans to assist customers affected by Hurricane Ida - Katapult announced its plans to assist its customers and the communities directly affected by Hurricane Ida. "Our thoughts and prayers are with the communities devastated by Hurricane Ida. Our primary concern is the safety and well-being of our customers, retail partners, and the communities that have been devastated by this storm," said Orlando Zayas, CEO of Katapult. "Our team at Katapult is working quickly to facilitate support and provide relief to those who need it so they can focus on what's most important, their safety." As part of its plan to provide assistance to the surrounding communities, Katapult is taking the following actions: Donating $50,000 to the American Red Cross to support the relief efforts in Louisiana and Mississippi; and extending hardship support to its customers in impacted areas via temporary payment reductions on regular lease payments. In addition, Katapult is reaching out to its customers and retail partners located in the directly affected area to see how they can further support them during this time.

09:05 EDT Axis Capital announces promotion of Usman Malik to Chief Pricing Actuary - AXIS Insurance, a unit of AXIS Capital Holdings, announced the promotion of Usman Malik to Chief Pricing Actuary. In this role, Mr. Malik will lead pricing strategy across the global Insurance segment, centered around enabling a consistent and global approach for portfolio construction. He will work in partnership with group underwriting and Insurance segment business leaders to establish pricing that supports the underwriting process and aligns with the Company's risk and profitability thresholds. Mr. Malik is based in the Company's London office.

09:05 EDT Apple announces first states to rollout adding license, state ID to Wallet - Apple announced that it is working with several states across the country, which will roll out the ability for their residents to add their driver's license or state ID to Wallet on their iPhone and Apple Watch. Arizona and Georgia will be the first states to introduce this new innovation to their residents, with Connecticut, Iowa, Kentucky, Maryland, Oklahoma, and Utah to follow. The Transportation Security Administration, or TSA, will enable select airport security checkpoints and lanes in participating airports as the first locations customers can use their driver's license or state ID in Wallet. Built with privacy at the forefront, Wallet provides a more secure and convenient way for customers to present their driver's licenses and state IDs on iPhone or Apple Watch.

09:03 EDT Paylocity acquires Blue Marble Payroll, terms not disclosed - Paylocity announces the acquisition of Blue Marble Payroll, a longtime partner providing international payroll solutions. Blue Marble is a leading global payroll provider for companies seeking more control and convenience in international payroll processes and currently serves approximately 450 clients. Blue Marble's platform enables U.S.-based companies to manage payroll for employees outside the U.S. in line with complex local and country-specific requirements across more than 150 countries. Paylocity has worked with Blue Marble since its start in 2013, helping shared clients with their international payroll needs. As more economies around the world open and companies increasingly look for talent anywhere while enabling more flexibility for where employees work, the challenge of managing international payroll has increased. Through Paylocity's acquisition of Blue Marble and its approximately 75 employees, clients will be able to better manage their international workforces through a unified solution to pay employees, automate processes, and stay compliant with local regulations in other countries. Paylocity expects Blue Marble to represent less than 2% of total revenue in fiscal 2022. Paylocity will update financial guidance in the normal course of business in their first quarter fiscal 2022 earnings release.

09:02 EDT Information Analysis says SBA loan program begins operating - Information Analysis Incorporated announced that the modernization of the Fiscal Transfer Agent of the U.S. Small Business Administration 7(a) Loan Program and Secondary Market project on which IAI has been a critical team member for over a year has begun operating. The newly modernized system will allow the FTA program through its partners to better perform loan servicing, technology modernization, and financial services for SBA's loan programs, which have grown to over 7,500 lenders and nearly one trillion in assets. The 7(a) loan program grew substantially during this modernization process as the Paycheck Protection Program and its constantly-evolving guidance is administered under the 7(a) program. IAI was engaged by the prime contractor to join a technology team for the enhancement, transformation, and modernization of SBA's current 7(a) Loan system environment, which includes complex legacy computer systems.

09:01 EDT Angi Inc. appoints Dhanusha Sivajee as Chief Marketing Officer - Angi announced the appointment of Dhanusha Sivajee to Chief Marketing Officer, effective September 7, 2021. As CMO, Sivajee will oversee the company's brand marketing vision, strategy and execution for both homeowners and pros. Sivajee most recently served as CMO of The Knot Worldwide.

09:00 EDT Palantir Technologies commits to equity stake in BlackSky, size undisclosed - BlackSky Holdings announced that Palantir Technologies(PLTR) has committed to making an equity investment in BlackSky, which is scheduled to close after the completion of BlackSky's business combination with Osprey Technology Acquisition (SFTW). Following the successful completion of a joint pilot program between BlackSky and Palantir, this investment signifies the strengthening of a strategic collaboration that will enable BlackSky to further extend its capabilities and meet the increasing demand for global monitoring services from its and Palantir's customers. Through the pilot project, BlackSky automatically delivered insights and intelligence to Palantir customers within minutes of collection, without any human interaction. The ability to quickly deliver worldwide intelligence that can inform proactive strategic decision-making introduces a significant advantage in time-sensitive operations. "This collaboration further enables BlackSky to put the power of real-time intelligence in the hands of the user by allowing Palantir customers to directly task our satellites, reduce decision-making timelines and increase the delivery of on-demand insights," said Brian E. O'Toole, CEO of BlackSky. "Our partnership with Palantir will accelerate our go-to-market plan, expanding our pipeline of commercial and government customers around the world."

08:53 EDT Nova Lifestyle provides update on Las Vegas Market Summer 2021 - Nova LifeStyle is pleased to announce, Diamond Sofa, a wholly owned subsidiary of the Company, participated at Las Vegas Market Summer 2021 which took place August 22 - 26. "We are very pleased to receive the positive feedback from current and prospective clients like Rapport, Lamps Plus, Regency, Coco Furniture Gallery and Slumberland with 120 stores across twelve states as well as the interaction we had with manufacturers, retailers and other businesses that support the furniture business," Tawny Lam, Chairperson and Chief Executive Officer of Nova LifeStyle stated. "We are very proud to have launched several new upholstery collections, that capture the latest in-demand style while incorporate modular aspect and flexibility with comforts." The Diamond Sofa showroom saw a steady flow of buyers attracted by fresh product introductions and product availability. Buyers at the show included US top-100 and international retailers, in addition to interior and event designers in the trade

08:50 EDT ADX signs agreement with Nasdaq for marketplace technology solutions - Abu Dhabi Securities Exchange announced that it has taken a key step towards launching a derivatives market this year by signing an agreement with Nasdaq to deliver marketplace technology solutions, including matching, real-time clearing and settlement technology. ADX is rapidly expanding asset classes and developing new offerings for both regional and international investors. The ADX General Index has recently reached 7700 points for the first time, supported by a series of listings and increased participation by international investors. In addition, the index has gained 52% year to date, making it one of the best performing equity indexes in the world. The exchange plans to launch single stock futures and index futures in the fourth quarter of this year before expanding to a wider range of derivative products. The initiative will further diversify investment avenues and provide investors with hedging tools for effective risk management. The derivatives market will be accompanied by introducing central counterparty clearing to promote clearing efficiency, stability and confidence in the market.

08:48 EDT One Medical appoints Mary Ann Tocio to board of directors - One Medical announced the appointment of Mary Ann Tocio to its board of directors. Ms. Tocio is the former President and Chief Operating Officer of Bright Horizons Family Solutions, and joins the board with over 30 years of leadership and operational experience.

08:43 EDT Delta Air Lines, Spotify partner for playlists on Delta seatback screens - In a blog post, Delta (DAL) said, "Every journey has a story that can be told in music, which is why Delta and Spotify (SPOT) are partnering to reimagine the in-flight audio experience exclusively on Delta Studio. Beginning in September, customers on Delta will be able to listen to specially curated versions of Spotify's most popular playlists and more than 40 select podcast series curated by Spotify and Delta directly from the airline's industry-leading seatback screens.The partnership brings together the world's most awarded airline with the world's largest audio streaming service. Spotify reaches more than 365M monthly active users in 178 markets around the world - helping listeners connect with culture through music, podcasts and curated content that reflects the world around them. Available only on Delta, customers can enjoy eight specially curated versions of Spotify playlists that feature tastes of some of Spotify's most popular playlists, including: Mood Booster, Relax & Unwind, RapCaviar and Hot Country. In the same way the airline regularly refreshes Delta Studio with new hit movies and TV shows from top studios, these curated playlist mixtapes and podcasts will be regularly updated and expanded with new tracks and episodes to ensure customers always have the latest hits and new playlists during their journey - including selections from artists and genres they might not have discovered yet." Reference Link

08:40 EDT Riskified and Wayfair further pact to optimize omnichannel, while cutting fraud - Riskified (RSKD) announced its partnership renewal with Wayfair (W). Wayfair plans to deploy Riskified's risk management solutions and deliver new, dynamic channels that will delight its customers and suppliers. In 2018, Wayfair partnered with Riskified to automate and scale its approach to payment fraud. Since then, Wayfair has gained a significant return on investment, greatly reducing fraud losses and false declines while minimizing customer friction. Riskified enables a frictionless eCommerce experience through its proprietary machine learning platform that reviews every transaction in order to accurately approve legitimate purchases while protecting the merchant from fraud. Extending their partnership will allow Riskified and Wayfair to continue solving complex problems related to online shopping, checkout and payments. Both are dedicated to using next-generation technology to improve the eCommerce journey. Wayfair is reinventing the way people shop for their homes through constant innovations, from proprietary search and product visualization to an end-to-end global logistics network. Riskified pioneered the chargeback guarantee model for fraud management and is the only enterprise-focused partner providing it as a core service for the largest and the fastest-growing eCommerce brands in the world.

08:39 EDT ABVC BioPharma announces new PCT filings for MDD, ADHD treatments - ABVC BioPharma announced it has filed new PCT applications in connection with its medicines that treat major depressive disorder, or MDD, and Attention-Deficit Hyperactivity Disorder, or ADHD. The two PCT applications describe the treatment methods of oral administrating compositions containing Radix Polygalae extract, or PDC-1421. PDC-1421 is the active ingredient for both the company's MDD and ADHD drugs. A recently completed Phase II Part II clinical study for ABVC's MDD medicine was a randomized, double-blind, placebo-controlled, multi-center trial, involving 60 adult patients with confirmed moderate to severe MDD who were treated with PDC-1421 three times a day for six weeks. PDC-1421 met the pre-specified primary endpoint by demonstrating a highly significant 13.2-point reduction in the Montgomery-Asberg Depression Rating Scale total score by Intention-To-Treat analysis, averaged over the 6-week treatment period from baseline, as compared to 9.2-point reduction of the placebo group. "We believe that the PCT filings, which provide quick entries to PCT contracting countries, such as China, Japan and European Union, can facilitate the global IP protection of our important MDD and ADHD products," said Dr. Howard Doong, ABVC BioPharma chief executive officer. "The PCT's and subsequent national phase applications, when granted, can extend our product's global market exclusivity to 2040~2041."

08:38 EDT Daxor CEO Feldschuh provides corporate update in letter to shareholders - Daxor announces it issued a corporate update in a Letter to Shareholders filed in its certified shareholder report on form N-CSR on August 30, 2021, from CEO & President, Michael Feldschuh: "I have never been more excited about the progress of our company or the prospects for our business in the time ahead. Daxor has been working hard for years as the global leader in blood volume measurement technology to drive sales and adoption of our novel FDA-cleared diagnostic in the healthcare system... In 2022, Daxor plans on launching its new point-of-care blood volume analysis systems, developed under multiple contracts by the US Department of Defense, or US DOD, a significant leap forward in our market-leading technology and the most important product launch in 20 years for the company. Our new systems are planned to be three times faster, simpler, and as announced in March of this year will have an option for a novel fluorescing marker as well as a nuclear tracer for use in new care settings beyond our current systems. To realize that promise and the enormous market potential for our products requires the company to execute on three key areas of performance: strong commercialization, next-generation product development, and continued clinical outcomes. Beginning with financial performance, the Company is pleased to report a 26.5% increase in the unaudited revenues of our blood volume diagnostic operating division for the six-month period ended June 30, 2021, as compared to the same period in the prior year. Revenue growth was driven by a combination of the sale and leasing of our capital equipment to hospitals and orders for our single-use blood volume diagnostics kits for heart failure management, critical care use, as well as other indications... Accelerating commercialization is a priority for Company management... Importantly, Daxor entered into agreements in the first half of this year with two distributors to amplify the reach of our products at hospitals not covered by Daxor's own reps. Management anticipates that there will be sales force of over 50 composed of Daxor's territory managers, clinical support team, and third-party distributor reps backed by Daxor's internal marketing team... Equally important is the progress that Daxor has made in the area of clinical outcomes utilizing our blood volume analyzer systems. In May of this year Management announced a landmark grant from the National Institutes of Health awarded to Daxor and investigators at the VA Hospital system for a prospective randomized multi-center blood volume trial for the treatment of heart failure with Daxor's systems. This multi-phase study has already begun and will add to the significant evidence of the impact of blood volume guided care in reducing HF readmissions and mortality.... The Company also announced in August that a promising research letter on the use of Daxor's BVA-100 analyzer on six COVID-19 patients at NYU Medical center had been published in the prestigious Journal of Critical Care. Daxor's prospective multi-center trial has enrolled more than 50% of its goal and results are expected later this year... The third area of focus of the company has been the vital research and development of next generation Blood Volume Analyzers, or BVA... The US DOD and the Center for Advancing Point of Care Technology have awarded the Company an additional four contract awards for Daxor's next generation blood volume analyzer.. Management anticipates that there will be significant interest and uptake of the new systems based upon preliminary discussions with clinicians helping to develop the technology. Daxor's next generation devices will also be eligible for Phase III funding awards and acquisition by branches of the military for their deployment to aid in combat casualty care."

08:37 EDT Energy Transfer signs solar power purchase deal with SoftBank unit SB Energy - Energy Transfer (ET) announced it signed a 15-year Power Purchase Agreement with San Francisco-based SB Energy (SFTBY) for 120 megawatts of electricity from its Eiffel Solar project in northeast Texas. Energy Transfer is a Fortune 100 midstream energy company based in Dallas. "We are pleased to announce this PPA with SB Energy," said Tom Mason, head of Energy Transfer's Alternative Energy Group. "It is our second significant agreement to purchase low-cost solar power to help us meet our ERCOT load requirements for our operations throughout Texas. The first was the Maplewood 2 solar farm in the Permian Basin that came online earlier this year." SB Energy, a wholly owned subsidiary of SoftBank Group Corp., is scheduled to begin construction of the 200-megawatt Eiffel Solar project located in Lamar County the first half of 2022. The project will start to deliver energy to Energy Transfer in January of 2024.

08:36 EDT Freddie Mac to ramp up Low-Income Housing Tax Credit equity investments - Freddie Mac will begin ramping up its Low-Income Housing Tax Credit equity investments, which support affordable housing throughout the United States. The move comes in response to the Federal Housing Finance Agency's announcement that it has increased the annual cap on Freddie Mac's LIHTC Equity investments from $500 million to $850 million. Freddie Mac has provided approximately $500 million in LIHTC Equity investments each year since reentering the market in 2018.

08:33 EDT Global Ship Lease repurchases of 521,650 shares, insider purchases 2.5M shares - Global Ship Lease announced that B. Riley Financial has purchased 3 million Class A common shares from Kelso & Company at a price of $19.17 per share, a discount of 5% to the closing price on August 31, 2021. 521,650 of the Acquired Shares were subsequently purchased from B. Riley at the same cost of $19.17 by Global Ship Lease's Executive Chairman George Youroukos, and a further 521,650 were purchased by the Company from B. Riley at the same cost and will be retired, reducing the issued and outstanding shares of the Company to 36,216,803. Following these transactions, Kelso's remaining holdings of Global Ship Lease have been reduced to approximately 4.9% of shares outstanding, while Mr. Youroukos's holding has increased to approximately 6.4% of shares outstanding.

08:31 EDT Sify Technologies enters channel partnership with Colt Technology Services - Sify Technologies announced a channel partnership with Colt Technology Services. The partnership introduces Sify's collaborative practices for Oracle Cloud Infrastructure, the Infrastructure-as-a-Service that delivers on-premises computing power to run cloud-native and enterprise company's IT workloads. This is made possible by Colt's network connectivity capability with its On Demand service allowing specifically for connectivity to be flexed up for the OCI migration. Translated, that means, the customer gets the additional connectivity only when it is required.

08:30 EDT Seaspan announces order for five 7,000 TEU dual-fuel LNG containerships - Seaspan, a wholly owned subsidiary of Atlas Corp. (ATCO), announced that ZIM Integrated Shipping Services (ZIM) has exercised its option to enter into long-term charters of five ultra-modern 7,000 TEU dual-fuel liquefied natural gas containership newbuilds . ZIM was granted this option in connection with the agreement to charter ten vessels of the same class announced on July 6th, 2021. Seaspan will enter into agreements with a major shipyard to construct the LNG Containerships, which are anticipated to be delivered during the fourth quarter of 2024. The LNG Containerships are anticipated to be financed from existing liquidity, cash flow from operations, and additional borrowings.

08:25 EDT Diversey appoints Rod Hochman to board of directors - Diversey Holdings has appointed Rod Hochman, M.D. to the company's board of directors, effective September 1, 2021. This appointment will bring the total number of directors to ten. Rod Hochman, M.D. has been the President and Chief Executive Officer of Providence, a not-for-profit health system since 2013.

08:25 EDT Saputo completes acquisition of Carolina Aseptic, Carolina Dairy businesses - Saputo announces that it has completed the acquisition of the Carolina Aseptic and Carolina Dairy businesses formerly operated by AmeriQual Group Holdings. These businesses, which join Saputo's Dairy Division under its USA Sector, are conducted at two facilities in North Carolina and employ a total of approximately 230 people. The purchase price of $118M, on a cash-free and debt-free basis, was paid in cash at closing. Carolina Aseptic develops, manufactures, packages, and distributes aseptic shelf-stable food products and beverages out of a purpose-built facility in Troy, North Carolina. Nearby, Carolina Dairy manufactures, packages, and distributes refrigerated yogurt in spouted pouches in Biscoe, North Carolina. The acquisition of these businesses will better position Saputo to capture the growing demand for aseptic protein beverages and nutritional snacks.

08:22 EDT Coherus, Junshi announce completion of rolling BLA submission for toripalimab - Shanghai Junshi Biosciences and Coherus Biosciences announced the completion of the rolling submission of the Biologics License Application to the U.S. Food and Drug Administration for toripalimab in combination with gemcitabine and cisplatin for first-line treatment for patients with advanced recurrent or metastatic nasopharyngeal carcinoma and toripalimab monotherapy for second-line or above treatment of recurrent or metastatic NPC after platinum-containing chemotherapy. The FDA recently granted Breakthrough Therapy Designation for toripalimab in combination with chemotherapy for 1st line treatment of recurrent, locally advanced or primary metastatic non-keratinizing nasopharyngeal carcinoma and earlier in 2020 granted BTD for toripalimab monotherapy for patients with recurrent or metastatic non-keratinizing NPC with disease progression on or after platinum-containing chemotherapy. BTD is intended to expedite the development and regulatory review of drugs where preliminary clinical evidence demonstrates substantial improvement over existing therapies for a severe or life-threating disease. Drugs with BTD will be granted more frequent FDA interaction and intensive guidance - including that from senior FDA officials - on the development program and ability to participate in various forms of expedited FDA review programs to provide patients with new therapy as soon as possible. The submission is supported by the results from "POLARIS-02" and "JUPITER-02". The POLARIS-02 study is a multi-center, open-label, pivotal Phase II clinical study, results of which were published online in January 2021 in Journal of Clinical Oncology. The JUPITER-02 study is a randomized, double blind, placebo-controlled pivotal Phase 3 clinical trial, results of which were recently presented at the ASCO plenary session and published in the August 2021 on-line edition of Nature Medicine.

08:20 EDT Singing Machine annouces release of Carpool Karaoke Microphone 2.0 - The Singing Machine Company announces the official product release of its Carpool Karaoke Microphone 2.0. The new product release follows the success of the first version of the Carpool Karaoke Microphone which became a sensation on TikTok last year. The next generation microphone has been reimagined with expanded capabilities to better target social media based consumers.

08:17 EDT Kansas City Southern receives unsolicited proposal from Canadian Pacific - Kansas City Southern (KSU) announced that it has received an unsolicited proposal from Canadian Pacific (CP) reaffirming its interest in acquiring KCS. In its proposal, CP reiterated identical terms to the proposal made on August 10, whereby holders of KCS common stock would receive 2.884 CP common shares and $90 in cash for each share of KCS common stock held. In addition, CP reiterated that holders of KCS preferred stock would receive $37.50 in cash for each share of KCS preferred stock held. On May 21, KCS announced that it had entered into a definitive agreement with CN (CNI), pursuant to which CN agreed to acquire KCS in a stock and cash transaction valued at $325 per KCS share based on the CN and KCS closing prices on May 12. The transaction is subject to customary closing conditions including receipt of regulatory approvals and the approval of KCS stockholders. The KCS board will evaluate CP's proposal in accordance with the terms of KCS' merger agreement with CN and respond in due course.

08:15 EDT Alta Equipment Group acquires Baron Industries for less than $2M - Alta Equipment Group announced that it has acquired Baron Industries, a privately held dock & door company based in Woburn, Massachusetts. Baron is an established, leading provider of dock and door sales, service, and installation for the greater New England area. The company specializes in commercial overhead loading dock doors and equipment, hydraulic lifts, and vertical reciprocating conveyors. Baron generated approximately $6M in revenue and had adjusted EBITDA of approximately $400,000 in the latest fiscal year. The purchase price includes certain tangible assets such as inventory, vehicles, and an $800,000 goodwill premium. The total purchase price is expected to be less than $2M, subject to customary post-closing purchase price adjustments.

08:13 EDT Immutep last patient enrolled, dosed in Stage 2 Part B of TACTI-002 study - Immutep announces that the last patient has been enrolled and safely dosed in Stage 2 of Part B of its Phase II TACTI-002 study. This completes the recruitment of 2nd line PD-1/PD-L1 refractory non-small cell lung cancer patients into the trial. Immutep expects to report further data from TACTI-002 at a scientific conference in calendar year 2021 or early calendar year 2022. Patient recruitment is now complete for Parts B and C of TACTI-002 and continues to progress well for the expansion stage of Part A. A total of 154 patients out of up to 183 are now participating in TACTI-002 at currently 19 clinical sites across Australia, Europe, the UK and US.

08:11 EDT Lineage Cell Therapeutics appoints George Samuel III as general counsel - Lineage Cell Therapeutics announced that it has appointed George Samuel III as Lineage's general counsel and corporate secretary. Samuel will lead the company's legal operations, bringing extensive corporate, transactional, intellectual property and commercial expertise which spans nearly 15 years across the life sciences and technology sectors as well as in private practice. Prior to joining Lineage, Samuel most recently served as director, senior counsel for Lytx, where he managed the commercial legal operations for an international video telematics SaaS company.

08:10 EDT Elys Game Technology receives operator license for Washington D.C. - Elys Game Technology announced the grant by the District of Columbia's Office of Lottery and Gaming, or OLG, of a Class B Operator license to Grand Central to operate a sportsbook within the Grand Central Restaurant & Bar and of a provisional Class B Standard Management Services Provider License to the company in conjunction with management services to be provided to Grand Central. The Grand Central venue will offer sports betting alongside food and beverages providing a customer experience and is believed to be the first sportsbook of its kind to be operated within an independently owned business establishment in the U.S. The Class B license allows a full-service sportsbook with no restrictions on maximum bets to be wagered and where all winnings can be redeemed on-site. Elys will provide Grand Central with the turn-key retail betting solution on POS and kiosk hardware as well as managed services to operate the sportsbook, including back-office and business intelligence, odds and event offerings, risk management and trading services, while both Elys and Grand Central will collaborate on customer-engagement campaigns, marketing, and any co-branding ventures. To allow sufficient time for staff training and hardware installation, it is expected that wagering on sports will be offered at Grand Central in or around October with the on-premise mobile app to be launched in 2022.

08:09 EDT H2O Innovation's specialty chemicals selected to provide antiscalant - H2O Innovation announced that its specialty chemical business line has been selected to provide antiscalant to the world's largest seawater reverse osmosis desalination plant. Operated by ACWA Power, a leading developer, investor and operator of long-term contracted power generation and desalinated water projects worldwide, the Taweelah plant is designed to treat 240 MGD. The plant is located in the United Arab Emirates. H2O Innovation's Piedmont business had previously secured the sale of its fiberglass reinforced plastic cartridge filter housings to the plant. Through a highly competitive bid process, which considered the complete technical offering, logistics, dosage, and price, the Corporation's unique dendrimer-based SpectraGuard 100 was selected as the optimal chemical to inhibit membrane scaling and fouling at this mega-desalination plant. The product's high level of functional end groups on SpectraGuard 100's molecular surface binds up hardness to disperse silt and inorganic colloids, while the internal cavities sequester organic molecules, making the product ideal for seawater applications.

08:07 EDT Coherus, Junshi announce completion of rolling BLA submission for toripalimab - Shanghai Junshi Biosciences and Coherus Biosciences announced the completion of the rolling submission of the Biologics License Application to the U.S. Food and Drug Administration for toripalimab in combination with gemcitabine and cisplatin for first-line treatment for patients with advanced recurrent or metastatic nasopharyngeal carcinoma and toripalimab monotherapy for second-line or above treatment of recurrent or metastatic NPC after platinum-containing chemotherapy. The FDA recently granted Breakthrough Therapy Designation for toripalimab in combination with chemotherapy for 1st line treatment of recurrent, locally advanced or primary metastatic non-keratinizing nasopharyngeal carcinoma and earlier in 2020 granted BTD for toripalimab monotherapy for patients with recurrent or metastatic non-keratinizing NPC with disease progression on or after platinum-containing chemotherapy. BTD is intended to expedite the development and regulatory review of drugs where preliminary clinical evidence demonstrates substantial improvement over existing therapies for a severe or life-threating disease. Drugs with BTD will be granted more frequent FDA interaction and intensive guidance - including that from senior FDA officials - on the development program and ability to participate in various forms of expedited FDA review programs to provide patients with new therapy as soon as possible. The submission is supported by the results from "POLARIS-02" and "JUPITER-02". The POLARIS-02 study is a multi-center, open-label, pivotal Phase II clinical study, results of which were published online in January 2021 in Journal of Clinical Oncology. The JUPITER-02 study is a randomized, double blind, placebo-controlled pivotal Phase 3 clinical trial, results of which were recently presented at the ASCO plenary session and published in the August 2021 on-line edition of Nature Medicine.

08:06 EDT Generac announced acquisition of Apricity Code Corporation - Generac announced the acquisition of Apricity Code Corporation, an engineering and product design company. Apricity's team of engineers is experienced in designing and prototyping energy-related products to increase reliability, add functionality, and improve performance. "Adding Apricity to the Generac team will accelerate our efforts to provide a broader energy technology portfolio and increase our speed to market for both our Clean Energy and Grid Services products and solutions," commented Aaron Jagdfeld, President and Chief Executive Officer of Generac. "We are very pleased to have this talented group of engineers join our team." Terms of the deal were not disclosed.

08:05 EDT Asensus Surgical receives FDA clearance for ISU expansion - Asensus Surgical announced that it has received 510 clearance from the FDA for an expansion of machine vision capabilities on the previously cleared Intelligent Surgical Unit, or ISU. The ISU is utilized with the company's Senhance Surgical System which enables Digital Laparoscopy.

08:04 EDT Oportun Financial appoints Roy Banks, Rick Welts to board of directors - Oportun Financial Corporation announced the addition of two new independent board members to its diverse Board of Directors. Effective as of September 1, 2021, the appointments expand Oportun's board from nine to eleven members with the additions of Roy Banks and Rick Welts. Roy Banks is the Chief Executive Officer of Weave Communications, Inc, an all-in-one customer communication and engagement platform for small businesses. Rick Welts has more than 45 years of experience in the NBA, primarily as a league and team executive, most recently as President and Chief Operating Officer of the Golden State Warriors. With these additions, Oportun's board now includes eight of eleven members who identify as members of an underrepresented group.

08:03 EDT TD Holdings enters strategic cooperation agreement with Jinyibao International - TD Holdings announced that the company has entered into a strategic cooperation agreement on August 31 with Jinyibao International Technology Company Limited, a technology company engaged in global gold spot trading business. The Agreement shall be in effect until August 31, 2023. Pursuant to the Agreement, JIT plans to reach its goal of $3B in gross merchandise volume from global gold spot trading within three years and its target markets include but are not limited to China, India, Southeast Asia, the Middle East, Europe and North America. The company agrees to tailor a supply chain service plan for JIT and provide supporting services along the supply chain according to JIT's needs, such as supply chain procurement services and sales, inventory pledge financing, accounts receivable management, factoring, financial support, and leasing.

08:03 EDT Seelos Therapeutics announces CFO and CCO appointments - Seelos Therapeutics promoted Michael Golembiewski to CFO and Anthony Marciano to Chief Communications Officer, each effective September 1. Golembiewski joined Seelos in January 2019 as VP, Finance. Previously, he was VP of Finance at Agile Therapeutics. He was also VP of Finance, Principal Accounting Officer and Corporate Controller at Pernix Therapeutics. Marciano began his work with Seelos as a consultant in August 2017 and was appointed Head of Corporate Communications in January 2019. Marciano began as a healthcare-dedicated institutional equity salesman at Leerink, Swann and Company in 2000 and immediately prior to Seelos served as a Senior Vice President at Jefferies.

07:59 EDT IBM partners with Adobe to teach basic design to adolescents - IBM (IBM) is providing no-cost, online coursework and a digital badge credential in a collaboration with Adobe (ADBE). The collaboration is designed to help prepare students, particularly those from under-resourced backgrounds, for academic and professional careers by teaching them basic design principles and creativity tools. All coursework is provided at no cost to learners through IBM's SkillsBuild for Students program. IBM SkillsBuild for Students provides no-cost visual design coursework that aims to help teens be more successful when they begin careers.

07:50 EDT Brown-Forman backs FY22 underlying net sales view up mid-single digits - The company said, "Due to the volatility and uncertainty that continues to exist in the operating environment, including recent COVID-19 trends and global supply chain disruptions, we have revised some of our expectations for fiscal 2022. Currently, we are managing through the impact of global supply chain disruptions, including glass supply, and have deployed a number of risk mitigation strategies to address the various constraints on our business. While we expect these disruptions to persist throughout the fiscal year, we believe the impact will become less significant in the second half of the year. We expect a more significant unfavorable impact from supply chain disruptions and higher input costs related to agave, transportation costs, and commodity prices to negatively impact our gross margin. As a result of these factors, we expect gross margin to be flat, or slightly down, for the full year versus the slight improvement originally expected. Despite these challenges, we still anticipate mid-single digit growth in underlying net sales, underlying operating expenses, and underlying operating income for fiscal 2022. As a result of these factors coupled with unusual comparisons to last year, we expect the seasonality of our results to be volatile during the year. We expect our effective tax rate to be in the range of about 22-23%."

07:44 EDT Entourage Health announces new ticker symbol on OTCQX market - Entourage Health announced that effective at market open on September 1, 2021, the OTCQX market ticker symbol for the Company's common shares will change from "WDDMF" to "ETRGF". The OTCQX symbol change is consistent with the Company's rebranding from WeedMD Inc. to Entourage Health Corp. announced earlier this year. The Company's common shares continue to trade primarily on the TSX Venture Exchange under the symbol "ENTG" and Frankfurt Stock Exchange under the symbol "4WE".

07:35 EDT Rigel Pharmaceuticals' fostamatinib meets Phase 2 safety endpoint - Rigel Pharmaceuticals announced the publication of results from a Phase 2 clinical trial evaluating the safety of fostamatinib for the treatment of hospitalized patients with COVID-19, in a publication of the Infectious Disease Society of America. For COVID-19 patients requiring hospitalization, fostamatinib in combination with the standard of care was shown to be well tolerated in the study. Patients treated with fostamatinib had less severe adverse events, and were observed to have improved clinical outcomes compared to those receiving placebo and standard of care. Results from the Phase 2 trial demonstrated that the addition of fostamatinib to standard of care was well tolerated and associated with clinically meaningful improvement in clinical outcomes in hospitalized COVID-19 patients who required supplemental oxygen. While the study was not powered to test clinical efficacy, numerous prespecified secondary endpoints consistently favored fostamatinib, suggesting that fostamatinib may provide an additional therapeutic benefit compared to current SOC alone. Fostamatinib was superior to placebo in accelerating improvement in clinical status from baseline by Day 15. Despite general SOC use of both steroids and remdesivir in all 59 patients, there was a consistently greater reduction in NETosis and other inflammatory biomarkers in the fostamatinib group compared to the placebo group.

07:33 EDT Daktronics CEO expects volatility in revenue cycles, production costs - CEO Reece Kurtenbach added, "Our solid backlog and strong pipeline of opportunities positions us for a successful year. However, as we work through supply chain challenges, we expect volatility in our revenue cycles and production costs. Over the long-term, we believe the fundamentals of the audiovisual industry are strong and are poised for growth. We are actively investing in capacity and in new technologies and markets to meet that expected demand with world-leading solutions and value. We look forward to the continued global economic recovery and long-term profitable growth."

07:32 EDT Xeris Pharmaceuticals completes enrollment of Its Phase 1 study of levothyroxine - Xeris Pharmaceuticals announced that the company has completed enrollment and successfully dosed all participants in a Phase 1 study of levothyroxine or XP-8121, to evaluate the pharmacokinetics, safety and tolerability, and potential for weekly dosing of the investigational, novel, subcutaneous injection for the treatment of hypothyroidism. XP-8121 is a novel formulation that could potentially mitigate many of the challenges associated with oral formulations, such as identification of an ideal dose due to absorption variation and medication adherence for patients who have difficulty maintaining a stable, therapeutic serum level. Preclinical studies of SC XP-8121 showed a sustained plasma exposure profile and similar maximum plasma concentration when compared with equivalent doses of the oral formulation.

07:28 EDT Shell aims to install 50,000 EV charge posts in the UK by 2025 - Shell sets an ambition to have 50,000 on-street electric vehicle charge posts installed across the UK by the end of 2025, through ubitricity, part of the Shell group. The move is part of a wider effort to bring more EV charging availability to the millions of UK drivers without private parking and help local authorities get their charging networks up-and-running as quickly as possible. Around 3,600 ubitricity chargers are already in place in the UK, using existing street infrastructure such as lamp posts and bollards. In order to drive take-up to reach the 50,000 figure, Shell will support local authorities with a financing offer to install more ubitricity on-street chargers in towns and cities across the UK at potentially zero cost. The UK government's Office for Zero Emission Vehicles currently meets 75% of the cost of installing on-street chargers through the On-Street Residential Charging Scheme. For local authorities looking to install ubitricity charge posts, Shell is prepared to cover the remaining costs, subject to commercial terms. Globally, Shell wants to grow its electric vehicle network from more than 60,000 charge points today to around 500,000 by 2025. This is part of its broader target to be a net-zero emissions energy business by 2050, in step with society's progress in achieving the goal of the UN Paris Agreement on climate change. Reference Link

07:19 EDT Herman Miller increases use of ocean-bound plastic with Aeron Chair - Herman Miller's entire portfolio of Aeron Chairs will contain ocean-bound plastic, including a new color, Onyx Ultra Matte, which contains up to 2.5 pounds of mismanaged plastic waste found near waterways per chair. These material changes in the Aeron Portfolio are projected to save the ocean from over 150 tons of plastic annually. The updates are part of Herman Miller's membership in NextWave Plastics, its long-term goal to increase recycled content to at least 50% including the use of ocean-bound plastic across all material the company uses by 2030. The company is also adding ocean-bound plastic to returnable shipping crates and poly bags used to keep products safe during transit. Ocean-bound plastic is plastic material that has not yet found its way into the ocean and is classified as "mismanaged waste." This is plastic that is not being collected, is unlikely to be collected, and is found within 50 kilometers of a coastline.

07:16 EDT Nabriva Therapeutics reports inducement grants under Nasdaq listing rule - Nabriva Therapeutics announced that it has granted non-statutory stock options to purchase an aggregate of 32,130 ordinary shares of Nabriva Therapeutics as an inducement to three newly-hired employees. These grants were awarded pursuant to the Nasdaq inducement grant exception as a component of new hire employment compensation. The stock options were granted effective August 31, 2021 with an exercise price of $1.06 per share, which is equal to the closing price of Nabriva Therapeutics' ordinary shares on the date of grant. Each stock option granted has a 10-year term and vests over four years, with 25% of the original number of shares vesting on the annual anniversary of the grant date until fully vested, subject to the employee's continued service with the Company through the applicable vesting dates. The stock option awards were approved by Nabriva Therapeutics' Compensation Committee and were granted as an inducement material to each employee's acceptance of employment in accordance with Nasdaq Listing Rule 5635(c)(4). Each of the stock options is subject to the terms and conditions of a stock option agreement covering the grant and Nabriva Therapeutics' 2021 Inducement Share Incentive Plan.

07:15 EDT Standard Lithium provides update on El Dorado, Arkansas project - Standard Lithium offered an update on the installation of the SiFT lithium carbonate plant at its flagship South Arkansas project and other related developments. The installation of the 'SiFT' lithium carbonate plant is completed, with all major connections made to the existing plant, and the installation of a new weatherproof enclosure. 'Wet' commissioning of the SiFT Plant is ongoing, and it is expected that fully integrated operations will commence during September. Standard Lithium has also installed and commissioned a novel osmotically assisted High Pressure Reverse Osmosis unit at the demonstration plant in El Dorado. This unit sits between LiSTR and SiFT and is used to concentrate the lithium chloride product continuously produced by the existing LiSTR Direct Lithium Extraction plant, so that it can then be converted to lithium carbonate. The HPRO unit is now operational and is being integrated into the overall process flow at the plant. Standard Lithium also issues an update on the company's status following Hurricane Ida. In advance of the storm, Standard Lithium's team in Arkansas engaged pre-emptive emergency safety protocols to secure the plant, critical infrastructure and team at the El Dorado site. Standard Lithium personnel ensured all equipment was moved to a safe, staging area to protected against possible storm damage. Ultimately, with a shift in Hurricane Ida's path, operations continued without interruption. Standard Lithium has also announced its latest corporate citizenship efforts to support the El Dorado community. In September, Standard Lithium, alongside LANXESS and others, will be a major sponsor for the "22nd Annual SouthArk Outdoor Expo!" being hosted by the South Arkansas Community College Foundation on Saturday, September 11, 2021. In October, Standard Lithium will be a 'Superstar Sponsor' for the "Main Street El Dorado Musicfest 2021" which will feature performances by the likes of Frank Foster and Ice Cube.

07:13 EDT Green Thumb Industries acquires GreenStar Herbals, terms not disclosed - Green Thumb Industries announced it has acquired GreenStar Herbals, Inc., which owns and operates two adult-use retail locations in Massachusetts. The acquisition includes a third retail location, set to open in 2021 near Logan International Airport and the Encore Casino. With the acquisition of GreenStar Herbals Inc., the Company has two operational adult-use retail stores in Dracut and Maynard, with a third to open in Chelsea this year, and three medical-use retail stores in Amherst, Boston and West Springfield. Green Thumb's existing Rise Amherst store reverted to a medical cannabis store in August. The Massachusetts recreational cannabis market has sold more than $1.5 billion in cannabis products since launching adult-use sales in 2018, according to the state's Cannabis Control Commission, with daily sales averaging over $3 million so far in 2021. Adult-use cannabis sales in the state have reached nearly $755 million so far in 2021 and is projected to reach $1.2 billion by the end of the year.

07:12 EDT Silence Therapeutics appoints John Strafford as SVP, business development - Silence Therapeutics announced the appointment of John Strafford, Ph.D., to the newly created role of Senior Vice President, Business Development, Alliance Management and New Product Development, effective immediately. John joined Silence in 2018 and has served as Vice President, Head of Business Development and member of the Executive Leadership Team since 2019. In his new role, John will continue to drive all business development and alliance management activities as well as lead the new product development function, helping to define the future commercial strategy for the Company's proprietary mRNAi GOLD development pipeline.

07:09 EDT BioCryst announces HHS purchases additional 10,000 doses of RAPIVAB - BioCryst Pharmaceuticals announced that the U.S. Department of Health and Human Services, or HHS, has exercised its option to purchase an additional 10,000 doses of BioCryst's antiviral influenza therapy, RAPIVAB, for approximately $7M. The RAPIVAB purchase by the HHS Office of the Assistant Secretary for Preparedness and Response will supply the Strategic National Stockpile. The order is part of a $34.7M contract the Centers for Disease Control and Prevention awarded in 2018 for the procurement of up to 50,000 doses of RAPIVAB over a five-year period for the SNS. With the fulfillment of this new order, BioCryst will have delivered 40,000 doses under the contract.

07:09 EDT Piedmont Lithium submits two applications related to Carolina Lithium Project - Piedmont Lithium announced it has submitted two applications related to the company's Carolina Lithium Project. On August 30, the company filed its application for a North Carolina State Mining Permit with the N.C. Department of Environmental Quality's Division of Energy, Mineral and Land Resources. Additionally, on August 31, the company submitted a draft loan application to the U.S. Department of Energy's Loans Program Office for loan funding via the Advanced Technologies Vehicle Manufacturing Loan Program. The ATVM has $17.7B in direct loan authority to provide funding to U.S. companies engaged in the manufacturing of fuel efficient, advanced technology vehicles and qualifying components supporting the automotive supply chain. The timeline for the review and response with respect to each application is subject to the established processes and procedures of the respective responsible agency.

07:08 EDT Greenlane, KushCo complete merger - Greenlane Holdings (GNLN) and KushCo Holdings (KSHB) announced the completion of their previously announced merger. The combined company, operating as Greenlane, brings together two of the pioneering cannabis ancillary product and service companies with more than 26 years of operating history to create an undisputed leader in the cannabis industry. The Company's Class A common stock will continue to trade on the Nasdaq Global Market under the ticker symbol "GNLN". Each KushCo stockholder is entitled to receive 0.3016 of a Greenlane Share for each share of KushCo common stock held on August 31, 2021, the effective date of the Transaction. Holders of Greenlane Shares prior to the completion of the Transaction will continue to hold their Greenlane Shares with no adjustment as a result of the Transaction. KushCo's common stock has ceased trading on the OTCQX effective as of the close of trading on August 31, 2021. Greenlane expects the Transaction to yield a number of important strategic synergies and financial benefits allowing for enhanced scale and rapid growth: Establishes the leading ancillary cannabis company delivering more value to customers across the supply chain: Greenlane serves a premier group of customers, including many of the leading multi-state-operators and licensed producers, the top smoke shops in the United States, and millions of consumers worldwide. Optimized platform with significant synergies: The Company expects to generate approximately $15 million to $20 million of annual run-rate cost synergies within 24 months from the closing of the Transaction. These synergies are expected to result from the economies of scale that will be realized following the Transaction, an optimized nationwide distribution network, and reduced operating expenses. Strengthens best-in-class proprietary brands and exclusive third-party brand offerings: As the leading supplier of premier consumer brands and products, Greenlane offers its customers a diversified and highly complementary product offering. Robust organic growth through cross-selling opportunities: the Company has the wide-ranging breadth of products and services needed to support the entire global cannabis industry. Unique ability to drive industry innovation and premier product design and development: With over 200 articles of Intellectual Property, the Company will cultivate a strong innovation pipeline across a broad category of product offerings, supported by an industry-leading and experienced product development and design team. Effective on closing, Greenlane's senior management team and Board of Directors are as follows: Senior management team: Nick Kovacevich, Chief Executive Officer; Bill Mote, Chief Financial Officer; Aaron LoCascio, President; Adam Schoenfeld, Chief Strategy Officer; Rodrigo de Oliveira, Chief Operating Officer; Rhiana Barr, Chief People Officer; Douglas Fischer, General Counsel; Michael Cellucci, President, CPG Sales; Andrew Goodman, SVP of Sales. Board of Directors: Jeff Uttz, Independent Director; Rich Taney, Independent Director; Dallas Imbimbo, Independent Director; Donald Hunter, Independent Director; Nick Kovacevich, Director; Aaron LoCascio, Director; Adam Schoenfeld, Director.

07:07 EDT Orthofix announces 1st US pediatric implant of Fitbone limb-Lengthening system - Orthofix Medical announced the first U.S. pediatric patient implanted with the Fitbone intramedullary lengthening system implant for limb lengthening of the femur and tibia bones. The Fitbone system is the only intramedullary limb lengthening solution cleared by the U.S. Food and Drug Administration for pediatric and adult use and is available in a 9mm, 11mm and 13mm sizes to address the specific needs of patients. The system is now compatible with the OrthoNext digital platform, the only software tool in the market for deformity analysis and preoperative planning for pediatric and adult orthopedic procedures. The OrthoNext software features a reverse planning method module that simulates the target position, osteotomy level and blocking screw placement - enabling a more accurate preoperative assessment.

07:04 EDT Domino's Pizza opens first store in Lithuania - Domino's Pizza is continuing to expand globally, following the opening of the first Domino's store in Lithuania. Residents of Vilnius can now enjoy hot, made-to-order pizza as they dine in or carry-out or choose to have it delivered to their door by master franchisee Morgacita Limited. A second location will open soon in Vilnius on Ateities Street with additional locations planned in the future, with the intent of creating more than 400 jobs in the next three years.

07:04 EDT Advent Technologies acquires the fischer Group's fuel cell system, no terms - Advent Technologies Holdings, announced that it had successfully closed its acquisition of Serenergy A/S and fischer eco solutions GmbH , the fuel cell business of the fischer Group. SerEnergy, which operates facilities in Aalborg, Denmark, and in Metro Manila, Philippines, is a leading manufacturer of high-temperature polymer electrolyte membrane fuel cells globally, with thousands of systems shipped around the globe during its 15 years of operation. The company employs approximately 75 people across its two locations in research and development production, sales and service, all with expertise in the area of HT-PEM fuel cell systems. SerEnergy manufactures remote, off-grid power fuel cell systems that are a natural fit for Advent's "Any Fuel. Anywhere." strategy and portfolio. FES, which operates out of a facility on fischer Group's campus in Achern, Germany, provides fuel-cell stack assembly and testing as well as the production of critical fuel cell components, including membrane electrode assemblies bipolar plates, and reformers. Effective as of the closing of the transaction, Advent entered into a lease for the portion of the fischer Group's campus used by FES. Its 17 employees, along with all of SerEnergy's employees, are expected to remain with Advent. Dr. Vasilis Gregoriou, Chairman and CEO of Advent, remarked, "We are excited to welcome the highly skilled and innovative team of SerEnergy and fischer eco solutions to the Advent family. The technical expertise and manufacturing capabilities of our new colleagues in Denmark and Germany are an excellent match for our strategic growth plan. We expect the SerEnergy off-grid and telecom-tower products to benefit significantly from Advent's product development advances in new materials. In return, we expect that the manufacturing experience they bring will further accelerate our go-to-market plan. This acquisition is expected to position Advent as a fuel cell leader with the ability to deliver thousands of systems per year in the off-grid, portable, and other power-generation markets, with capacity in place."

07:02 EDT Space industry companies form Digital IF Interoperability Consortium - Leading companies and organizations in the space industry, including two major branches of the U.S. Department of Defense, have come together to form the Digital IF Interoperability (DIFI) Consortium, a non-profit industry group created to advance interoperability among space and ground system networks. Formed under the auspices of The IEEE Industry Standards and Technology Organization (ISTO), an international federation of leading industry groups and consortia dedicated to the advancement of standardized technologies for the benefit of industry. The founding board members include Hawkeye 360, Intelsat Corp., Kongsberg Satellite Services AS, Kratos Defense & Security Solutions, Kymeta Corp. and Microsoft, as well as founding government member the U.S. Navy. Other U.S. military service branches have also expressed interest in working with the Consortium. The mission of DIFI is to enable the digital transformation of space, satellite and related industries by providing a simple, open, interoperable Digital IF/RF standard that replaces the natural interoperability of analog IF signals and helps prevent vendor lock-in. The newly formed consortium is in the process of implementing administrative structures and recruiting additional member companies and organizations with an interest in space networks to become active participants in DIFI.

07:01 EDT AxoGen RECON study completes subject follow-up - Axogen announced that the RECON Clinical Study supporting its Biologics License Application for Avance Nerve Graft has completed follow-up of study subjects. RECON reached its enrollment target of 220 subjects in July 2020. The study remains on schedule with a top line study data read-out expected in the second quarter of 2022, followed by filing of the BLA submission in 2023. RECON compares Avance Nerve Graft to manufactured conduits in digital nerve injuries with a primary endpoint of recovery of static two-point discrimination, a measure of sensation, and secondary endpoints for quality of life and subject satisfaction. The BLA will transition Avance Nerve Graft from a human tissue product to a biological product. "We are pleased to have reached this milestone and thank the study investigators and research teams for their dedication and commitment to this landmark study," commented Karen Zaderej, chairman, CEO, and president of Axogen. "The RECON study is designed to provide Level 1 clinical data for our BLA, and will provide additional evidence for surgeons in their clinical decision making for the repair of peripheral nerve injuries."

06:56 EDT Dollar General looking to hire additional employees - Dollar General is looking to hire additional employees to serve its customers and communities with opportunities currently available in stores, distribution centers, the DG Private Fleet and its Store Support Center. These efforts come on the heels of the company's successful hiring initiative in which more than 50,000 employees have been hired since mid-July.

06:48 EDT Merck and Ridgeback begin Phase 3 study of molnupiravir in COVID-19 infection - Merck and Ridgeback Biotherapeutics initiated the Phase 3 MOVe-AHEAD clinical trial to evaluate molnupiravir, an investigational oral antiviral therapeutic, for the prevention of COVID-19 infection. The global study is enrolling individuals who are at least 18 years of age and reside in the same household as someone with laboratory-confirmed SARS-CoV-2 infection with symptoms. The safety and efficacy of molnupiravir is also currently being evaluated in Part 2 of the ongoing MOVe-OUT trial, which is a global Phase 3 study of non-hospitalized adult patients with laboratory-confirmed mild to moderate COVID-19 and at least one risk factor associated with poor disease outcomes. Data from the study is expected in the second half of 2021. Participants are not eligible for the trial if they have received the first dose of a COVID-19 vaccine more than seven days prior to enrollment, have previously had COVID-19 or are showing any signs or symptoms of COVID-19.

06:47 EDT Dada Nexus, JD.com and ASUS enter fulfillment partnership - Dada Group (DADA) and JD.com (JD), as well as ASUS, announced the forming of a partnership with a focus on digital transformation of offline stores to improve fulfillment efficiency and one-hour shopping experience for laptops and computer accessories. To date, over 150 ASUS stores in China have launched on JD.com and JD Daojia, Dada's on-demand retail platform. By the second half of 2021, the one-hour shopping service will cover all ASUS stores in China. When consumers order via JD.com and the JDDJ platform, ASUS laptops and computer accessories are delivered from the nearest ASUS store within one hour by Dada's riders. Through the partnership, the three companies will collaborate in product management, digital marketing, refined user operation and optimization of fulfillment efficiency.

06:35 EDT Cathie Wood's ARK Investment bought 194K shares of Zoom Video on Tuesday - Shares of Zoom Video are up 0.8% at $291.74 in early pre-market trading.

06:32 EDT Mitsubishi Group invests additional $120M in Mars Growth fund - Mitsubishi Group has injected another $120M investment into the Mars Growth fund, a 50/50 joint venture owned by MUFG and Liquidity Capital. MUFG has a broader strategic relationship with Liquidity and this latest investment represents their cumulative investment of $220M to date.

06:29 EDT Skillz up another 7% in pre-market trading at $12.58 per share - Shares of Skillz are up about 7% at $12.58 in pre-market trading following yesterday's 11.1% advance. The stock is in the top-10 highest trending tickers on StockTwits and top-5 on WallStreetBets Reddit thread in terms of message volume over the past 24 hours.

06:12 EDT HP Enterprise builds research supercomputer for Japan's University of Hyogo - Hewlett Packard Enterprise has built a new supercomputer for the University of Hyogo, a public university in Japan. The new supercomputer uses HPE Apollo systems to target modeling, simulation and artificial intelligence capabilities to advance investigations into society's issues. This is the university's third generation supercomputer to run big data sets involving complex scientific data across meteorology, manufacturing, physics and medicine. The capabilities will also help increase accuracy in outcomes through the use of AI and machine learning. University of Hyogo's new supercomputer is built using HPE Apollo 6500 Gen10 and HPE Apollo 2000 Gen10 systems featuring NVIDIA V100 Tensor Core GPUs.

06:07 EDT Conn's raises FY22 SSS growth view to mid-teens from high single digits - "Strong second quarter retail and credit results exceeded our expectations and demonstrate that our growth strategies are taking hold. Second quarter same store sales increased 16.4% and total retail sales are up 24.0% over the prior year period. Strong retail performance combined with a second quarter credit spread of 1,200 basis points, contributed to record second quarter earnings per diluted share. In fact, earnings per diluted share of $2.74 for the first six months of the year are higher than any annual earnings in Conn's 131-year history," stated Chandra Holt, Conn's CEO. "Momentum remains positive across our business reflecting strong consumer demand and the growth strategies we have put in place. Total retail sales for the first half have increased at the fastest growth rate in seven years. As a result, we are increasing our fiscal year 2022 same store sales expectation from high single-digit same store sales growth to mid-teens same store sales growth," continued Holt.

06:05 EDT Standard Motor acquires Stabil Operative Group, sees accretion - Standard Motor announced that it has acquired 100% of the capital stock of Stabil Operative Group, a German company. Stabil is a manufacturer and distributor of a variety of components, including electronic sensors, control units, and clamping devices to the European OE market, servicing both commercial and light vehicle applications. Stabil generates approximately $25M in annual revenue and has facilities in Germany and Hungary. SMP will fund the acquisition in cash through borrowings under its revolving credit facility. It is anticipated the acquisition will be accretive to diluted earnings per share in 2022.

05:46 EDT XPeng reports August deliveries of 7,214 vehicles, up 172% - XPeng announced its vehicle delivery results for August. In August, XPeng delivered 7,214 Smart EVs, representing a 172% increase year-over-year. Deliveries in August consisted of 6,165 P7s, the company's sports smart sedan, and 1,049 G3s, its smart compact SUV. In total, 2021 year-to-date deliveries reached 45,992 vehicles, representing a 334% increase year-over-year. P7 deliveries continued to strengthen, achieving a record month in August and a 209% increase year-over-year. In August, the company began to transition production for the G3 SUV to G3i, the mid-cycle facelift version of G3, to its wholly-owned Zhaoqing Smart EV Manufacturing Base. As a result, some planned deliveries of the G3 were affected in August. The company expects to start deliveries of the G3i to start in September. On September 15, the company plans to officially launch the P5 family sedan, its third production model, with deliveries starting in October.

05:42 EDT Nio reports August deliveries of 5,880 vehicles, up 48.3% - Nio announced its August delivery results. Nio delivered 5,880 vehicles in August, representing a 48.3% year-over-year growth. While the Company's new order reached an all-time high in August driven by the increasing demand, the vehicle production, especially the manufacturing of the ES6 and EC6, was materially disrupted by supply chain constraints resulting from the COVID-19 pandemic in certain areas in China and Malaysia. The deliveries consisted of 1,738 ES8s, the Company's six-seater or seven-seater smart electric SUV, 2,342 ES6s, the Company's five-seater premium smart electric SUV, and 1,800 EC6s, the Company's five-seater smart electric coupe SUV. As of August 31, cumulative deliveries of the ES8, ES6 and EC6 reached 131,408 vehicles.

05:33 EDT iQIYI launches QIYU 3 VR headset - iQIYI launched its latest virtual reality, or VR headset, the QIYU 3. The launch event of the product, which was live-streamed to millions of fans via extended reality, or XR, technology, showcased the features of the QIYU 3 and unveiled a number of free games for the device.

05:26 EDT Philips initiates repair, replacement program for DreamStation following recall - Royal Philips announced an update in connection with the June 14 recall notification for specific Philips sleep and respiratory care devices that was issued to address potential health risks related to the polyester-based polyurethane sound abatement foam component in these devices. More than half of the affected devices in use globally are in the US. The vast majority of the registered affected devices in the U.S. to date are in the first-generation DreamStation product family. Philips received authorization from the FDA for the rework of the affected first-generation DreamStation devices, which consists of replacement of the PE-PUR sound abatement foam with a new material. Philips anticipates rework to commence in the course of September. In addition to the rework, the company has already started replacing certain affected first-generation DreamStation CPAP devices in the U.S. with DreamStation 2 CPAP devices. Philips remains in dialogue with the FDA with respect to other aspects of the recall notification and mitigation plan in the U.S. Philips is initiating the repair and replacement programs in other countries as well and expects to have these underway in the majority of its markets by the end of September. The company intends to complete the repair and replacement programs within approximately 12 months.

05:18 EDT Elbit Systems CFO Joseph Gaspar to switch roles, Kobi Kagan to succeed - Elbit Systems announced that, after 20 years as CFO of the company, and having held various managerial positions in Elbit Systems and its subsidiaries around the world for many years prior to that, Joseph Gaspar will become senior executive VP- business management. Kobi Kagan, currently serving as deputy GM and senior VP - finance and control of Elbit Systems Land, will replace Gaspar as EVP and CFO. The appointments will become effective as of April 1, 2022.

05:09 EDT Philips receives authorization from FDA for DreamStation rework - Royal Philips announced an update in connection with the June 14 recall notification for specific Philips sleep and respiratory care devices that was issued to address potential health risks related to the polyester-based polyurethane sound abatement foam component in these devices. Philips said it received authorization from the Food and Drug Administration for the rework of the affected first-generation DreamStation devices, which consists of replacement of the polyester-based polyurethane sound abatement foam with a new material. Philips anticipates rework to commence in the course of September. In addition to the rework, the company has already started replacing certain affected first-generation DreamStation CPAP devices in the U.S. with DreamStation 2 CPAP devices. Philips remains in dialogue with the FDA with respect to other aspects of the recall notification and mitigation plan in the U.S. Philips is initiating the repair and replacement programs in other countries as well and expects to have these underway in the majority of its markets by the end of September. The company intends to complete the repair and replacement programs within approximately 12 months. Shares of Philips are up 4% to $47.80 in premarket trading.